Click here to read the latest cannabis outlook.

With a new year for the cannabis market drawing closer, the Investing News Network (INN) turned to experts in the space to see what investors should keep an eye out for in 2020.


Companies in the sector are up against the possibility of a shrinking landscape as some players emerge on top while others begin to fall further behind.

On the other hand, in the US there’s also the chance that the historic Secure and Fair Enforcement (SAFE) Banking Act and the Strengthening the 10th Amendment Through Entrusting States (STATES) Act could open the doors for cannabis in the country and shorten the valuation gap between American cannabis firms and their Canadian counterparts.

Moving into 2020, big legislative moves in the US and the possible consolidation of the market could prove to be some of the most critical drivers of growth for the marijuana space.

Read on to learn what investors can look forward to — and what they should look out for — in 2020.

Cannabis outlook 2020: Passing of SAFE and STATES acts

Perhaps the biggest news to come out of the cannabis space in the US has been the possibility of federal cannabis legalization. Cannabis remains a delicate topic in the country since the drug is still listed as a Schedule I substance, along with heroin and ecstasy.

But in September, the SAFE Banking Act was passed in the US House of Representatives in a historic vote as the first cannabis-related legislation to work its way through US Congress.

If passed by the Senate, the act would protect financial institutions working with legal cannabis companies from federal interference.

The vote was followed by the passing of the Marijuana Opportunity Reinvestment and Expungement (MORE) Act in November by the House Judiciary Committee, which seeks to deschedule cannabis as an illicit substance, effectively making it legal.

Rishi Malkani, cannabis leader and partner at financial services firm Deloitte, told INN that the SAFE Banking Act would allow cannabis companies to list on senior exchanges in the US, shifting the financial center of marijuana away from Canada and fueling American firms with financing.

The sentiment was echoed by Charles Taerk and Doug Waterson, executives at Faircourt Asset Management. Currently, Faircourt acts as a sub-advisor to Ninepoint Partners’ cannabis-focused fund, the Ninepoint Alternative Health Fund.

Taerk and Waterson said increased flexibility for banking options coming from the legislative side would make acquiring capital much easier for US marijuana businesses.

“Having access to increased sources of capital will enable (multi-state operators) to grow without having to be involved in complicated cross-border financings,” the pair said, mentioning that the SAFE Banking Act could go into effect by early 2020.

Some experts, however, said legislative moves in the US might be a lengthier process than expected.

“From a political standpoint, there is still a long road ahead for this bill to become law,” said Mark Noble, senior vice president of exchange-traded fund (ETF) strategy at Horizons ETFs, since the SAFE Banking Act still needs approval from the Senate. Noble also said, though, that the passing of the various cannabis laws making their way through the legal system in the US could even out the playing field for business in Canada and the US when it comes to value assessments.

“The biggest catalyst of the movement going forward is US legalization, or at the least liberalization of marijuana laws at the federal level,” Noble told INN. “Given the discrepancy in the potential size of the Canadian and US markets, the multi-state operators seem quite undervalued, relative to Canada.”

Richard Carleton, CEO of the Canadian Securities Exchange, agreed and said the exchange is looking forward to “a decoupling of valuations between US multi-state operators and Canadian licensed producers” in 2020.

Cannabis outlook 2020: Consolidation to rule the sector

Apart from the ongoing legislative debates in the US, the overall marijuana space could see a fair bit of shrinking, some experts say, as continued merger and acquisition (M&A) activity could lead to larger, more established companies absorbing smaller firms with little capital or a weak internal structures.

Russell Stanley, an analyst with Beacon Securities, said he expects to see more M&A “as asset-heavy/cash-poor companies may need marriage partners in order to survive.”

And in a sector that has fallen victim to guidance withdrawals and less-than-stellar results from industry heavyweights like Aurora Cannabis (NYSE:ACB,TSX:ACB) and Canopy Growth (NYSE:CGC,TSX:WEED), experts have cautioned that the gap between companies that have firmly established themselves and those that haven’t will widen.

“We could see some of the companies dying on the vine if they can’t raise capital through the equity market. The only alternative is very expensive debt financing,” Noble noted. He said the issue may be felt most acutely in the US due to a dearth of involvement from American investors and financial institutions.

“I am worried that the growth of marijuana companies could be stifled, even though demand for marijuana and (cannabidiol)-related products will probably only increase over the next few years.”

In a previous interview with INN, MJBiz’s investor intelligence analysts, Craig Behnke and Mike Regan, agreed that the sector will see not only an M&A uptick, but full industry departures moving into 2020.

“I would suspect that we continue to see more companies either reducing their guidance, perhaps even running out of cash, maybe even a bankruptcy or two,” Behnke said.

Both Behnke and Regan said they expect to see companies getting scooped up at a massive discount because of the volatility that cannabis market has faced as of late.

Cannabis outlook 2020: Possible concerns to consider

Since the cannabis market is in a bit of a transitional stage, there are certain aspects that investors should be on the lookout for.

For one, investor attitudes continue to be king for now. But the blanket sentiment that has covered the entire cannabis sector has some experts concerned that investors are allowing singular developments to radiate out across the industry.

“On most days, it looks like the vast majority of cannabis stocks are still moving in unison, in either direction,” Stanley said. “There will be winners and losers, but it looks like the market is still challenged to distinguish one stock from another.”

But as investors begin to see firms as discrete entities, the sector could see a diversification in operations as well, where marijuana businesses move away from the vertically integrated structures that have been popular thus far.

EY’s cannabis strategic growth and risk leader, Ashley Chiu, told INN that already established cultivation and processing infrastructure could bring about the rise of contract cultivation and other specialized companies.

Malkani is of two minds on the phenomenon, however. He said the space could see new extractors coming to the market, but some companies may look to bring these kinds of services in house and actually increase their vertical integration. He added that the industry could also see more disruptive entries from outside industries.

Canada has its own unique problems to overcome, one being the regulatory headwinds that experts noted have suffocated the market.

It’s a concern for Taerk and Waterson, who said a slow retail store rollout in key provinces like Ontario and Quebec could make it difficult to gain traction with consumers, especially as new edible products are sent to shelves.

“Some of the restrictions surrounding Cannabis 2.0 products, particularly the dosage limit of 10 milligrams per package, may also impede sales,” the pair said, mentioning that without a fleshed out retail segment, Canadian licensed producers will be “challenged to grow top-line revenue in any meaningful way.”

Cannabis outlook 2020: Investor takeaway

Despite all of the issues facing the marijuana sector, some industry professionals remain hopeful about the future of cannabis.

“My guess is that the pendulum has swung too far in the negative direction, and 2020 will be a nice buying opportunity to build a reasonable exposure to the cannabis markets,” said Kip Meadows, CEO and founder of fund administration company Nottingham.

Meadows added that investors should move into the space with the understanding that short-term investments are no longer the way to go.

“Think longer term, pick a percentage of your investing portfolio you feel comfortable putting in a slightly riskier industry, and stick it in a drawer. Think long term. It works for the Warren Buffetts of the world,” Meadows told INN.

This is especially pertinent since the next few years could bear the fruits of the market’s labor. Noble said that more revenue from investments on the part of cannabis companies could come online in 2020 and 2021, which could attract equity investors back to the industry.

Obstacles facing the cannabis sector will continue to strain certain parts of the industry, but a more open regulatory framework in both Canada and the US and further growth by some of the larger marijuana firms could open up the chance for increased stability and returns on investment in 2020.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

CanBud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“CanBud” or the “Corporation”) is pleased to announce that it has closed the final tranche of its oversubscribed non-brokered private placement for aggregate gross proceeds of approximately $4,730,000 (the “Offering”).

The Corporation issued a combined total of 39,409,346 units (each a “Unit“) at price of $0.12 per Unit, with each Unit comprised of one common share in the capital of the Corporation (each a “Common Share“) and one common share purchase warrant (each a “Warrant“). Each Warrant entitles the holder to purchase one additional Common Share at an exercise price of $0.22 within 24 months of the closing of the Offering (the “Warrant Term“), provided, however that if the closing price of the Common Shares on the Canadian Securities Exchange (the “CSE“) (or any such other stock exchange in Canada as the Common Shares may trade at the applicable time) is $0.25 or greater per Common Share for a period of five (5) consecutive trading days at any time after the closing date of the Offering, the Corporation may accelerate the Warrant Term such that the Warrants shall expire on the date which is 30 days following the date a press release is issued by the Corporation announcing the reduced warrant terms.

Keep reading... Show less

Thoughtful Brands Inc. (CSE:TBI)(FSE:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands) announces that the letter of intent with Franchise Cannabis Corp. (“FCC”), previously announced in January, has been terminated. The previously announced European joint venture with FCC will continue and allow the Company to launch and tailor its products to European consumer demands

In connection with termination of the merger transaction with FCC, the Company has agreed to pay FCC $100,000 in cash and to issue FCC 5,000,000 common shares of the Company at a deemed value of $0.05 per share. The common shares will be subject to a four-month-and-one-day statutory hold period in accordance with applicable securities laws.

Keep reading... Show less

Mergers and acquisitions (M&A) in cannabis space have helped boost the industry to new levels.

Keep reading... Show less

Strategic sale of non-core assets by Lobe adds non-dilutive capital and shareholder value

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce, further to its press release dated February 23, 2021, that it has completed the sale to Ionic Brands Corp. (“Ionic Brands”) of Lobe’s non-core cannabis assets relating to Washington-based Cowlitz County Cannabis Cultivation Inc. (“Cowlitz”) held by Lobe’s subsidiary vendor, Green Star Biosciences Inc. (the “Transaction”).

Keep reading... Show less

Adding to its existing presence on the west coast of the United States, all five KOIOS™ flavours and all four Fit Soda™ flavours will be carried in Metropolitan Market stores beginning on Monday, March 22, 2021. Serving the Seattle-Tacoma area (population 3.87 million), Metropolitan Market is one of five chains under its parent firm Good Food Holdings, which has a total of 51 stores in California, Oregon, and Washington State.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that beginning on Monday, March 22, 2021, Koios’ entire line of canned beverage products will be sold at all locations of Metropolitan Market, an urban format supermarket chain in the Seattle-Tacoma area of Washington State. In Q1 2021, the Company announced multiple placements of its beverage products with regional grocers in markets on the west coast of the United States including Market of Choice in Oregon Jensen’s in Southern California and major natural grocery chain Sprouts Farmers Market which has a substantial west coast presence with over one third of its locations (360+ stores across 23 states) in California as well as Washington State 1 . The Company has also recently announced other developments relating to its expansion efforts being undertaken in 2021 such as an in-house beverage canning facility and distribution agreements with regional and national wholesale partners.

Keep reading... Show less